Creative Foam Corporation has acquired AccuMED, a prominent medical contract manufacturing division of Lear Corporation, enhancing its capabilities in the medical sector.

Target Company Overview

AccuMED, a division of Lear Corporation (NYSE: LEA), is a prominent provider of medical contract manufacturing and engineering services, primarily focusing on textile-based Class I and Class II medical devices. With a commitment to quality and excellence, AccuMED has established partnerships with leading medical Original Equipment Manufacturers (OEMs) both in the United States and globally. The company is headquartered in the Dominican Republic, where it has maintained ISO 13485 and FDA registered facilities for over 20 years, employing approximately 1,400 professionals dedicated to delivering superior manufacturing solutions.

Industry Overview

The medical manufacturing industry in the Dominican Republic is thriving, primarily due to the country's strategic geographical location and favorable economic conditions. Over the past decade, the Dominican Republic has established itself as a hub for medical device manufacturing, attracting numerous international firms seeking to leverage its cost-effective labor force. This booming sector is bolstered by the government's commitment to creating a business-friendly environment, encouraging foreign investment and technological advancements.

Moreover, the Dominican Republic's medical device industry benefits from a robust infrastructure that supports efficient manufacturing and distribution processes. The country's w

View Source

Similar Deals

GE HealthCare Intelerad

2026

Merger Medical Imaging Systems United States of America
Novartis AG Avidity Biosciences, Inc.

2026

Merger Proprietary & Advanced Pharmaceuticals United States of America
XenoTherapeutics, Inc. Repare Therapeutics Inc.

2026

Merger Bio Therapeutic Drugs United States of America
Eli Lilly Ventyx Bioscences

2026

Merger Bio Therapeutic Drugs United States of America
MSD (Merck & Co., Inc.) Cidara Therapeutics, Inc.

2026

Merger Proprietary & Advanced Pharmaceuticals United States of America
Charles River Laboratories PathoQuest

2026

Merger Bio Diagnostics & Testing France

Creative Foam Corporation

invested in

AccuMED

in 2025

in a Merger deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert